Z. Zeng

Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants

G. Iliakis, Nesrin Asaad, Z. Zeng, 2000, Oncogene.

Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells.

Huichen Wang, G. Iliakis, Z. Zeng, 2001, Nucleic acids research.

Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.

S. Powell, S. DiBiase, Huichen Wang, 2001, Cancer research.

The Radioresistance to Killing of A1–5 Cells Derives from Activation of the Chk1 Pathway*

Xiang Wang, G. Iliakis, Ya Wang, 2001, The Journal of Biological Chemistry.

Mitochondrial DNA deletions are associated with ischemia and aging in Balb/c mouse brain

Z. Zeng, T. Tong, M. Corbley, 1999, Journal of cellular biochemistry.

Caffeine Enhances MHCC97H Cell Line Radiosensitization by Shortening G2-Phase Arrest In Vitro

Z. Zeng, Zhao-you Tang, Shu-min Zhang, 2011 .

Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group

George Iliakis, Shunichi Takeda, Minoru Takata, 2001, Oncogene.

Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

G. Iliakis, Z. Zeng, J. DeFrank, 2001, Proceedings of the National Academy of Sciences of the United States of America.

DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus.

T Hyslop, W. Curran, T. Hyslop, 2000, Cancer research.

Evidence for factors modulating radiation-induced G2-delay: potential application as radioprotectors.

G. Iliakis, Z. Zeng, Y. Wang, 2001, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Maternal embryonic leucine zipper kinase in tumor cell and tumor microenvironment: Emerging player and promising therapeutic opportunities.

Z. Zeng, Si-wei Wang, S. Du, 2023, Cancer letters.